InoLife Technologies, Inc. Launches Ancestry DNA Test to the Consumer Market

RALEIGH, NC--(Marketwire - October 21, 2010) -

InoLife Technologies, Inc. (OTCBB: INOL), a service based healthcare products development, integration and marketing Company announced today the launch and marketing of its Ancestry DNA test for immediate availability to the consumer market.

InoLife Technologies, Inc. intends to capitalize on the recent popularity and the world’s increasing curiosity to discover one’s origins. It’s one thing to trace your ancestry through family history, but by using DNA to determine what part of the world your family’s ancestors originated and evolved from is even more accurate and fascinating.

Through the Company’s exclusive licensing and marketing agreement with InoHealth Products, Inc., InoLife’s marketing program will include a direct to the consumer approach, through direct response TV & radio campaigns, Internet marketing and print advertising. This very simple in-home DNA Ancestry testing process will compare the consumers DNA profile against hundreds of global populations and fourteen anthropological regions whose collective genetic information is known and scientifically validated. Their consumer is then measured with the likelihood that their genetic information is linked with each of those populations and regions. The customer receives the results and may elect to receive a plotted 17" by 10.5" very high-resolution map that illustrates their unique genealogical heritage from both the per-population view, and overall regional view.

Through its licensing agreement with IHP, InoLife Technologies, Inc. prides itself on the quality and accuracy of the DNA Ancestry testing process that benefits from their proprietary relationship with a CLIA approved human identity testing laboratory with accreditations such as the National Association of testing Laboratories (NATA), American Association of Blood Banks (AABB) and ISO 17025 certification to name a few. The product is backed by compiled data from scientific publications such as forensic Science International and The Journal of Forensic Sciences combined with the laboratories proprietary database.

In a recent interview, Gary Berthold, CEO of InoLife Technologies, Inc., stated, “We are pleased that we can now offer an excellent and accurate Ancestry testing process that is both convenient and easy to use for the many thousands of people that are truly interested in knowing where their families started out in this world.” Mr. Berthold continues by stating, “It is our goal to be considered the easiest to use, most refined and most importantly easy to understand DNA testing process on the market today.”

About InoLife Technologies, Inc.
InoLife is poised to become one of the premier U.S. marketers of state-of-the-art DNA-based test products. Positioned for growth and success in a burgeoning market, InoLife Technologies, www.inolifetech.com, is primarily focused on products, services and solutions that will enable state-of-the-art healthcare for today and the future for a diverse base of customers and end users. The Company’s mission is to identify, integrate and bring to market innovative healthcare-based products and services that provide timely and practical solutions. The primary products and services that InoLife is currently addressing focuses upon those specific products and services that provide key solutions through the innovative use of specific DNA testing and Genetic analysis systems.

The principal customers of InoLife’s products and services are healthcare providers, physicians, practitioners, hospitals and outpatient facilities. InoLife will be marketing and distributing its products through traditional distribution channels. Additionally InoLife has identified certain products that can be sold directly to consumers and has created specific programs to reach those customers including e-commerce, direct sales, healthcare providers, pharmacies, distributors, retail sellers and specialty retailers.